文献速递心血管CTMR

双能量心脏CT暗血成像评估左房纤维化与房颤复发

Dark-Blood Dual-Energy Cardiac CT for Evaluating Left Atrial Fibrosis, Atrial Fibrillation Type, and Post-Ablation Recurrence: A Retrospective Study Using Cardiac MR as Reference.
PubMed 文献 · Acad Radiol · 2026-01-12

回顾性纳入81例消融前房颤患者,以左房心脏MR为参考,评估双能量心脏CT暗血成像对左房纤维化、房颤分型及消融后复发的价值。结果显示DE-CCT对左房纤维化具有高特异度与中等敏感度,其在区分持续性房颤和预测1年复发方面与LA-CMR无显著差异。

要点

  • 暗血DE-CCT检出左房纤维化特异度高,可用于无MR替代评估。
  • DE-CCT所示纤维化节段增多是持续性房颤及消融后复发的重要预测因素。
  • 报告时可关注左房纤维化碘比值和受累节段数,辅助房颤风险分层。

核心结论

  • DE-CCT暗血成像对左房纤维化检测具有高特异度(100%,253/253节段)和中度敏感度(77.07%,242/314节段)。
  • 在区分持续性房颤(p=0.451)和1年早期复发(p=0.114)方面,DE-CCT与LA-CMR无显著差异。

研究设计与样本

  • 回顾性研究,纳入81例消融前房颤患者,排除合并其他心律失常或既往心脏手术者。
  • 采用双能量心脏CT暗血成像,注射对比剂后5分钟行碘定量,与同期左房心脏MR对照。
  • 以左房心脏MR作为评估左房纤维化的参考标准,59例完成消融后1年随访。

关键影像表现/征象

  • DE-CCT暗血图像可显示左房纤维化,与LA-CMR对照特异度为100%,敏感度为77.07%。
  • 左房纤维化与血池碘比值升高是持续性房颤的显著危险因素(OR=1.214,p=0.041)。
  • DE-CCT中左房纤维化节段增多与消融后1年复发相关(OR=2.130,p=0.009)。

诊断标准与关键数值

  • DE-CCT对左房纤维化节段诊断敏感度77.07%(242/314),特异度100%(253/253),准确度87.30%(495/567)。
  • DE-CCT模型预测持续性房颤AUC=0.965(p<0.001),LA-CMR模型AUC=0.954(p<0.001),两者无显著差异(p=0.451)。
  • DE-CCT纤维化节段增多、PeAF、甲状腺毒症及较高CHA2DS2-VASc评分可预测1年复发,AUC=0.895(p<0.001)。
  • LA-CMR对应1年复发预测AUC=0.869(p<0.001),与DE-CCT比较无显著差异(p=0.114)。
  • LA-CMR中左房纤维化节段增多也是持续性房颤的独立危险因素(OR=2.108,p=0.008)。

临床应用与阅片要点

  • 暗血DE-CCT碘定量可作为无法完成心脏MR患者的左房纤维化替代评估手段。
  • 阅片时应注意左房纤维化受累节段数量和左房纤维化/血池碘比值,这两项对房颤类型及复发具有预测价值。
  • 结合BNP、BMI、LAVI分级和CHA2DS2-VASc评分可提高对持续性房颤和消融后复发的风险判断。

局限性

  • 本研究为回顾性设计,存在选择偏倚和信息偏倚可能。
  • 仅81例患者且59例完成1年随访,样本量和随访规模有限。
  • 原文未提供多中心验证,结果的推广性有待进一步研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate the feasibility of dual-energy cardiac computed tomography (DE-CCT) in detecting left atrial fibrosis (LAF), atrial fibrillation (AF) classifications, and postablation recurrence, using left atrial cardiac magnetic resonance (LA-CMR) as reference.

MATERIALS AND METHODS: This retrospective study included 81 pre-ablation AF patients without concomitant other arrhythmia or prior cardiac surgery. DE-CCT (utilizing dark-blood images with 5-minute post-injection iodine quantification) was quantitatively compared to concurrent LA-CMR to assess LAF, AF types, and recurrence risk.

RESULTS: For LAF detection, dark-blood images manifested high specificity (100%, 253/253 segments), moderate sensitivity (77.07%, 242/314 segments), and satisfactory accuracy (87.30%, 495/567 segments) compared with LA-CMR. Increased iodine ratio of LAF to blood pool (OR = 1.214, p = 0.041), incremental LAF segments in DE-CCT (OR = 1.739, p = 0.050), elevated brain natriuretic peptide (BNP), higher body mass index, and worse degree of left atrial volume index (LAVI) were significant risk indicators for PeAF (AUC=0.965, p<0.001). Concerning LA-CMR, independent risk factors for PeAF were also elevated LAF segments in CMR (OR = 2.108, p = 0.008), BNP levels, and LAVI grades (AUC=0.954, p<0.001). Cumulatively, 59 patients completed 1-year follow-up postablation, with 30.5% experiencing recrudescence. Significant predictors for 1-year relapse included increased LAF segments in DE-CCT (OR = 2.130, p = 0.009) or LA-CMR (OR = 1.740, p = 0.039), PeAF, thyrotoxicosis, and larger CHA2DS2-VASc scores, yielding AUCs of 0.895 (p<0.001) and 0.869 (p<0.001), respectively. No significant differences were found between DE-CCT and LA-CMR in discerning PeAF (p = 0.451) and early relapse (p = 0.114).

CONCLUSIONS: DE-CCT is a viable alternative for evaluating LAF, AF subtypes, and high-risk recurrence, comparable to LA-CMR, potentially enabling personalized therapy and guiding further studies on higher-resolution multi-energy CT.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Chong, Like, Xu, et al. Dark-Blood Dual-Energy Cardiac CT for Evaluating Left Atrial Fibrosis, Atrial Fibrillation Type, and Post-Ablation Recurrence: A Retrospective Study Using Cardiac MR as Reference. Acad Radiol. 2026. PMID: 41530024. doi:10.1016/j.acra.2025.12.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。